T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas

T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas

18 Lượt nghe
T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas
🌏 Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) 🎓 Annual Scientific Meeting 2025 📅 Dates: 5–7 February 2025 📍 Venue: Room 1210, 12th Floor Bhumisiri Mangkhalanusorn Building Faculty of Medicine, Chulalongkorn University & King Chulalongkorn Memorial Hospital The Thai Red Cross Society, Bangkok, Thailand 🔬 Plenary Session 2: Cellular Immunotherapy II Featured Topic: T Cell Receptors and MHC Diversity in Risk, Prognosis, and Therapy for Gliomas 👨‍🏫 Speaker: Asst. Prof. Gary Kohanbash Director, PNIO Laboratory Faculty, Department of Neurological Surgery UPMC Children’s Hospital of Pittsburgh, USA